NEKTAR THERAPEUTICS·4

Sep 27, 6:09 PM ET

Lingnau Lutz 4

4 · NEKTAR THERAPEUTICS · Filed Sep 27, 2019

Insider Transaction Report

Form 4
Period: 2019-09-25
Lingnau Lutz
Director
Transactions
  • Award

    Stock Option

    2019-09-25+13,00013,000 total
    Exercise: $18.80Exp: 2027-09-24Common Stock (13,000 underlying)
  • Award

    Common Stock

    2019-09-25+6,50029,700 total
Footnotes (3)
  • [F1]This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.
  • [F2]This restricted stock unit award vests in full, one year following September 25, 2019.
  • [F3]This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION